Related Experiment Video
Updated: Apr 11, 2026

05:59
Blocking Lymph Flow by Suturing Afferent Lymphatic Vessels in Mice
Published on: May 14, 2020
7.2K
Anti-inflammatory effects of flap and lymph node transfer
Tiina P Viitanen1, Mikko T Visuri1, Eeva Sulo1
1Department of Plastic and General Surgery, Turku University Hospital, Turku, Finland.
The Journal of Surgical Research
|May 28, 2015
Summary
Flap transfer reduces inflammation after surgery. Lymph node transfer with flaps may also reduce fibrosis and improve lymphatic function in lymphedema patients.
Area of Science:
- Surgical reconstruction
- Tissue engineering
- Immunology
Background:
- Tissue transfer is common for wound repair and defect reconstruction.
- Microvascular lymph node transfer (LN) is a novel approach to enhance lymphatic function in lymphedema patients.
- Understanding cytokine profiles post-flap transfer is crucial for optimizing outcomes.
Purpose of the Study:
- To investigate the biological effects of flap transfer with and without lymph nodes.
- To analyze the production of key cytokines and growth factors in wound exudate.
- To elucidate the mechanisms behind the benefits of flap transfer in various patient groups.
Main Methods:
- Analysis of axillary wound exudate samples from four patient groups: axillary lymph node dissection (ALND), microvascular breast reconstruction (BR), LN transfer, and combined LN and BR (LN-BR).
- Quantification of proinflammatory, anti-inflammatory, prolymphangiogenic, and antilymphangiogenic cytokines and growth factors.
Main Results:
- Flap transfer groups exhibited a reduced proinflammatory cytokine response compared to the ALND group.
- The anti-inflammatory and antifibrotic cytokine IL-10 was elevated in the LN-BR group.
- LN and LN-BR groups demonstrated an overall anti-inflammatory cytokine profile.
Conclusions:
- Healthy tissue transfer mitigates the postoperative proinflammatory response, explaining its benefits in diverse surgical scenarios.
- Flap transfer incorporating lymph nodes appears to confer an antifibrotic effect.
- The therapeutic impact of LN transfer in lymphedema may involve increased vascular endothelial growth factor C (VEGF-C) and IL-10 production.

